Detalhe da pesquisa
1.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418685
2.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385243
3.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733229
4.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632738
5.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177902
6.
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
Am J Hematol
; 98(3): 449-463, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36594167
7.
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(8): 1031-1043, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35810754
8.
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.
Blood
; 136(18): 2038-2050, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731259
9.
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion.
Haematologica
; 106(9): 2354-2363, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054121
10.
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Ann Hematol
; 99(2): 277-282, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872362
11.
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
Oncologist
; 24(9): 1246-1252, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940746
12.
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
Oncologist
; 23(9): 1033-1038, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674440
13.
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.
Haematologica
; 103(8): 1345-1350, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748444
14.
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T-cell pathway in patients with diffuse large B-cell lymphoma.
Hematol Oncol
; 41(5): 947-950, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442805
15.
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
Hematol Oncol
; 36(1): 68-75, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28524259
16.
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study.
Haematologica
; 102(11): 1913-1922, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935843
17.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28775121
18.
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Ann Hematol
; 100(1): 303-304, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219839
19.
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.
J Transl Med
; 13: 229, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26174551
20.
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL112).
Leuk Lymphoma
; : 1-11, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598516